132077-74-8

Basic information

• Product Name: Aids000431
• Synonyms: 2,3-Oxetanedimethanol, 4-(6-amino-9H-purin-9-yl)-, (2alpha,3beta,4alpha)-2-amino-9-(2-deoxy-2-hydroxymethyl-.beta.-D-erythro-oxetanosyl)adenosine;2-Amino-9-(2-deoxy-2-hydroxymethyl-.beta.-D-erythro-oxetanosyl)adenosine;2-Amino-oxt-a;Aids000431;Aids-000431
• CAS NO: 132077-74-8
• Molecular Formula: C10H14N6O3
• Molecular Weight: 266.25656
• Mol File: 132077-74-8.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 720.8°Cat760mmHg
• Flash Point: 389.7°C
• Appearance: /
• Density: 2.08g/cm³
• Vapor Pressure: 8.32E-22mmHg at 25°C
• Refractive Index: 1.935
• CAS DataBase Reference: Aids000431(CAS DataBase Reference)
• NIST Chemistry Reference: Aids000431(132077-74-8)
• EPA Substance Registry System: Aids000431(132077-74-8)

Safety Data

• Hazardous Substances Data: 132077-74-8(Hazardous Substances Data)

Usage

InChI:InChI=1/C10H14N6O3/c11-7-6-8(15-10(12)14-7)16(3-13-6)9-4(1-17)5(2-18)19-9/h3-5,9,17-18H,1-2H2,(H4,11,12,14,15)/t4-,5-,9-/m1/s1

Upstream product

• 410094-03-0 N-[9-(3,4-bis-benzyloxymethyl-oxetan-2-yl)-9H-purin-6-yl]-benzamide 
• 4005-49-6 N-benzoyladenine 
• 410094-05-2 9-((2S,3S,4R)-3,4-Bis-benzyloxymethyl-oxetan-2-yl)-9H-purin-6-ylamine 
• 132454-54-7 Trifluoro-methanesulfonic acid (3R,4R,5S)-4,5-bis-benzyloxymethyl-2-oxo-tetrahydro-furan-3-yl ester 
• 132454-50-3 (2S,3R,4S)-3,4-Bis-benzyloxymethyl-oxetane-2-carboxylic acid methyl ester 
• 132454-53-6 (3R,4S,5S)-4,5-Bis-benzyloxymethyl-3-hydroxy-dihydro-furan-2-one 
• 132454-52-5 (2S,3R)-2,3-Bis-benzyloxymethyl-4-phenylsulfanyl-oxetane 
• 146820-71-5 (2S,3R,4S)-3,4-Bis-benzyloxymethyl-oxetane-2-carboxylic acid 
• 132454-56-9 (2S,3R,4S)-3,4-Bis-benzyloxymethyl-oxetane-2-carbonyl chloride 
• 132454-51-4 (2S,3R)-2,3-Bis-benzyloxymethyl-4-chloro-oxetane 
• 81722-81-8 1,2:5,6-Di-O-isopropyliden-3-C-<(trimethylsilyl)methyl>-α-D-allofuranose 
• 69827-91-4 3-deoxy-1,2-O-(1-methylethylidene)-3-<(phenylmethoxy)methyl>-5-O-(phenylmethyl)-α-D-ribofuranose 
• 26277-33-8 (R)-1-((3aR,5S,6R,6aR)-6-Hydroxymethyl-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-5-yl)-ethane-1,2-diol 
• 69827-89-0 ((3aR,5S,6R,6aR)-5-Hydroxymethyl-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-6-yl)-methanol 

Downstream Products

• 121885-21-0 Oxetanocin A N⁶-benzoate 

Relevant articles and documents

Synthesis of L-Oxetanocin

matrix presented Hitherto unknown L-oxetanocin has been synthesized from L-xylose in 16 steps via a ribonolactone derivative.

Oxetane derivatives

The present invention relates to an oxetane derivative represented by the general formula (I): STR1 wherein R1 and R2 are each an acyl group and R3 is a hydrogen atom or a lower alkyl group, which is useful as an intermediate for the preparation of a compound having a (bishydroxymethyl)oxetane structure in its saccharide moiety, for example, oxetanosine, and a process for the preparation of the same.

A TOTAL SYNTHESIS OF OXETANOCIN, A NOVEL NUCLEOSIDE WITH AN OXETANE RING

Oxetanocin has been synthesized starting from cis-2-buten-1,4-diol through α- or β-D-oxetanosyl acetate as an important intermediate which has an α-(methyl oxalyloxy)methyl group at C2-position.